Skip to main content
  • TAVR Still Safe, Effective in Low-Risk Patients at 4 Years – LRT Trial Results

    Transcatheter aortic valve replacement (TAVR) continued to be safe in patients with symptomatic, severe aortic stenosis who are at low surgical risk 4 years after the procedure, new trial results show.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details